Macrophages after myocardial infarction: Mechanisms for repairing and potential as therapeutic approaches

You Yang,Ai Wu,An-Ni Deng,Hao Liu,Qi Lan,Maryam Mazhar,Jin-Yi Xue,Ming-Tai Chen,Gang Luo,Meng-Nan Liu
DOI: https://doi.org/10.1016/j.intimp.2024.113562
IF: 5.714
2024-11-13
International Immunopharmacology
Abstract:Macrophages – one of the crucial immune cells, are recruited to the cardiac tissue by chemokines, cytokines and upregulated endothelial adhesion molecules after myocardial infarction (MI). During the course of inflammation in the cardiac tissue, necrotic cells and matrix debris is phagocytosed by M1 macrophages. During the resolution phase of cardiac inflammation, M2 macrophages promote cardiac recovery. Suppression or over expression of both the M1 and M2 macrophage subtypes significantly affect the reparation of infarction. Stem cells therapy, cytokine regulation and immune cells therapy are considered as effective interventions to regulate the phenotypic transformation of cardiac macrophages after MI. Intervention with macrophages in the myocardium has shown unique advantages. In this review, the mechanisms and role of macrophages in the development of MI are elaborated in detail, the promising therapeutic methods for regulating macrophage phenotypes, their limitations and possible future research directions are discussed.
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?